Novel Uses for Botulinum Neurotoxin in Upper Limb Surgery

References
1 Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidenced based review). Neurology 2008; 70: 1691-1698
2 Dumitrache A, Sanchez K, Esnouf S, Roren A, Vidal J, Rannou F, Poiraudeau S, Lefèvre-Colau MM. Physical therapy orthosis and occupational therapy in medical and surgical rheumatologic hand diseases. Presse Med 2013; pii:S0755-4982(13)00722-7. doi: 10.1016/j.lpm.2013.01.074
3 Aoki KR, Guyer B. Botulinum toxin A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. Eur J Neurol 2001; 18 (suppl 5) 21-9
4 Mannava S, Callahan MF, Trach SM, Wiggins WF, Smith BP, Koman LA et al Chemical denervation with botulinum neurotoxin A improves the surgical manipulation of the muscle-tendon unit: an experimental study in an animal model. J Hand Surg [Am] 2011; 36A (2) 222-231
5 Autti-Rämö I, Larsen A, Peltonen J, Taimo A, von Wendt L. Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia. Neuropediatrics 2000; 31 (1) 4-8
6 Ma J, Shen J, Smith BP, Ritting A, Smith TL, Koman LA. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat. J Bone Joint Surg Am 2007; 89 (10) 2241-2249
7 Kubat WD, Rekant M. Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures. Hand (N Y) 2008; 3 (3) 237-239
8 Tuzuner S, Balci N, Ozkaynak S. Results of zone II flexor tendon repair in children younger than age 6 years: botulinum toxin type A administration eased cooperation during the rehabilitation and improved outcome. J Pediatr Orthop 2004; 24 (6) 629-633
9 Matthews A, Moncrieff M, Logan A, Lindford A. Re: The use of Botulinum toxin after repair in a non-compliant adult patient. J Hand Surg Eur 2008; 33: 214
10 Stone AV, Koman LA, Callahan MF, Eckman DM, Smith BP, Plate JF et al The effect of botulinum neurotoxin-A on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon. J Hand Surg [Am] 2012; 37A (4) 795-802
11 Mannava S, Plate JF, Stone AV, Smith TL, Smith BP, Koman LA, Tuohy CJ. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A. J Hand Surg [Am] 2011; 36 (10) 1708-1710